FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea Print this page November 16, 2018 — The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the… Read More »
By DAVID SHAYWITZ MD At long last, we seem to be on the threshold of departing the earliest phases of AI, defined by the always tedious “will AI replace doctors/drug developers/occupation X?” discussion, and are poised to enter the more considered conversation of “Where will AI be useful?” and “What are the key barriers to… Read More »
A lie in can have consequencesAdam Kuylenstierna/EyeEm/Getty By Alice Klein Sleeping in on weekends may cause period pain by disrupting normal reproductive cycles, a study in female university students suggests. We already know that female shift-workers are more prone to irregular menstrual cycles, difficulties falling pregnant and miscarriages, possibly because their irregular schedules affect the… Read More »
Results of a much-anticipated trial on fish oil and vitamin D generated conflicting headlines last weekend. Some stories declared good news about the popular supplements: Reuters wrote that fish oil “can dramatically reduce the odds of a heart attack while vitamin D’s benefits seem to come from lowering the risk of death from cancer.” The… Read More »
Two industry initiatives that have worked together to advance interoperability are teaming again to further expand connectivity. Commonwell Health Alliance, a vendor-led organization that embeds interoperability services into health information systems, brings its 3-year-old health information exchange to the table. Carequality has been working on a governance framework that enables different networks to link to… Read More »